New sickle cell drug gets first human test: how does the body handle it?

NCT ID NCT07431398

First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 12 times

Summary

This early-stage study is testing a new drug called pociredir in 24 adults with sickle cell disease. Researchers want to see how the drug moves through the body when taken with or without food. The goal is to gather safety and dosing information, not to treat the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Advanced Pharma - Miami

    RECRUITING

    Miami, Florida, 33147, United States

    Contact Phone: •••-•••-••••

  • Neuro-Behavioral Clinical Research

    RECRUITING

    North Canton, Ohio, 44720, United States

    Contact Phone: •••-•••-••••

  • Omega Research Group

    RECRUITING

    Orlando, Florida, 32808, United States

    Contact Phone: •••-•••-••••

  • Sonar Clinical Research

    RECRUITING

    Riverdale, Georgia, 30274, United States

    Contact Phone: •••-•••-••••

  • University of Texas Health Science Center Houston

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • Worldwide Clinical Trials

    RECRUITING

    San Antonio, Texas, 78217, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.